Evidence map›Paper›PMID 32574189›Full record

ArticlePloS one2020

Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1.

Shin-Ichi Oka, Amira D Sabry, Amanda K Horiuchi, Keiko M Cawley, Sean A O'Very, Maria A Zaitsev, Thirupura S Shankar, Jaemin Byun, Risa Mukai, Xiaoyong Xu and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Genes · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. PERM1 regulates mitochondrial energetics through O-GlcNAcylation in the heart.Journal of molecular and cellular cardiology · 2025
    Article
  11. Article
  12. Article
  13. Adeno-associated virus-mediated gene delivery ofAmerican journal of physiology. Heart and circulatory physiology · 2024
    Article
  14. Review
  15. Article
  16. Cardiac maturation.Journal of molecular and cellular cardiology · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Shin-Ichi OkaDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States of America.
Amira D SabryNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Amanda K HoriuchiNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Keiko M CawleyNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Sean A O'VeryNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Maria A ZaitsevNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Thirupura S ShankarNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Jaemin ByunDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States of America.
Risa MukaiDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States of America.
Xiaoyong XuDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States of America.
Natalia S TorresNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.ORCID 0000-0002-8192-2562
Anil KumarMetabolic Phenotyping Core Facility, University of Utah, Salt Lake City, UT, United States of America.
Masayuki YazawaColumbia Stem Cell Initiative, Rehabilitation and Regenerative Medicine, Columbia University, New York, NY, United States of America.ORCID 0000-0002-5730-6583
Jing LingNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Iosif TalebNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Yukio SaijohDepartment of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT, United States of America.
Stavros G DrakosNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.
Junichi SadoshimaDepartment of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States of America.
Junco S WarrenNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, United States of America.ORCID 0000-0001-5231-4181
University of Utah · USRutgers, The State University of New Jersey · USColumbia University · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Cysteine oxidation in the heartR01HL091469 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI Junichi Sadoshima · 2008 to 2026
$9.4M
The Role of Serine Signaling in Compensatory Cardiac HypertrophyR01HL112330 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI Junichi Sadoshima · 2012 to 2026
$7.5M
Removal of damaged mitochondria by alternative autophagyR01HL138720 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SADOSHIMA, JUNICHI · 2017 to 2024
$4.7M
GSK-3beta inhibits lipotoxicityR01HL144626 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Junichi Sadoshima · 2019 to 2026
$3.0M
PPARα induces IL-6 to trigger diabetic cardiomyopathyR01HL150881 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SADOSHIMA, JUNICHI · 2020 to 2023
$2.2M
Clinical and Metabolic Signature of Recovered Myocardium in Human Heart FailureR01HL135121 · NHLBI · UNIVERSITY OF UTAH · PI DRAKOS, STAVROS GEORGE · 2017 to 2021
$1.9M
Cellular Remodeling in Heart Failure and after LVAD UnloadingR01HL132067 · NHLBI · UNIVERSITY OF UTAH · PI DRAKOS, STAVROS GEORGE, SACHSE, FRANK BERND · 2017 to 2020
$1.5M
Vevo 3100 High Resolution Imaging SystemS10OD025238 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2018 to 2018
$459k
NCI NIH HHS P30 CA042014NHLBI NIH HHS R01 HL091469NHLBI NIH HHS R01 HL112330NHLBI NIH HHS R01 HL132067NHLBI NIH HHS R01 HL135121NHLBI NIH HHS R01 HL138720NHLBI NIH HHS R01 HL144626NHLBI NIH HHS R01 HL150881NIH HHS S10 OD025238
6 · The paper itself

Abstract

The transcriptional regulatory machinery in mitochondrial bioenergetics is complex and is still not completely understood. We previously demonstrated that the histone methyltransferase Smyd1 regulates mitochondrial energetics. Here, we identified Perm1 (PPARGC-1 and ESRR-induced regulator, muscle specific 1) as a downstream target of Smyd1 through RNA-seq. Chromatin immunoprecipitation assay showed that Smyd1 directly interacts with the promoter of Perm1 in the mouse heart, and this interaction was significantly reduced in mouse hearts failing due to pressure overload for 4 weeks, where Perm1 was downregulated (24.4 ± 5.9% of sham, p<0.05). Similarly, the Perm1 protein level was significantly decreased in patients with advanced heart failure (55.2 ± 13.1% of donors, p<0.05). Phenylephrine (PE)-induced hypertrophic stress in cardiomyocytes also led to downregulation of Perm1 (55.7 ± 5.7% of control, p<0.05), and adenovirus-mediated overexpression of Perm1 rescued PE-induced downregulation of estrogen-related receptor alpha (ERRα), a key transcriptional regulator of mitochondrial energetics, and its target gene, Ndufv1 (Complex I). Pathway enrichment analysis of cardiomyocytes in which Perm1 was knocked-down by siRNA (siPerm1), revealed that the most downregulated pathway was metabolism. Cell stress tests using the Seahorse XF analyzer showed that basal respiration and ATP production were significantly reduced in siPerm1 cardiomyocytes (40.7% and 23.6% of scrambled-siRNA, respectively, both p<0.05). Luciferase reporter gene assay further revealed that Perm1 dose-dependently increased the promoter activity of the ERRα gene and known target of ERRα, Ndufv1 (Complex I). Overall, our study demonstrates that Perm1 is an essential regulator of cardiac energetics through ERRα, as part of the Smyd1 regulatory network.

Indexed as

AdultAgedAnimalsDisease Models, AnimalDNA-Binding ProteinsDNA MethylationDown-RegulationElectron Transport Complex IEnergy MetabolismERRalpha Estrogen-Related ReceptorFemaleGene Expression RegulationGene Knockdown TechniquesHeart FailureHeart TransplantationHistonesDNA-Binding ProteinsElectron Transport Complex IERRalpha Estrogen-Related Receptorhistone H3 trimethyl Lys4HistonesIntracellular Signaling Peptides and ProteinsMuscle ProteinsNDUFV1 protein, mousePERM1 protein, humanPERM1 protein, mousePhenylephrineReceptors, EstrogenRNA, Small InterferingSmyd1 protein, mouseTranscription Factors

Identifiers

PMID32574189
PMCPMC7310723
OpenAlexW3038021529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.